A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis
- PMID: 24458311
- PMCID: PMC4042514
- DOI: 10.1378/chest.13-1984
A comparison of health-related quality of life in idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis
Abstract
Background: Patients with interstitial lung disease (ILD) have poor health-related quality of life (HRQL). However, whether HRQL differs among different subtypes of ILD is unclear. The aim of this study was to determine whether HRQL was different among patients with idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis (CHP).
Methods: We identified patients from an ongoing longitudinal cohort of patients with ILD. HRQL was assessed using the Short Form (SF)-36 medical outcomes form (version 2.0). Regression analysis was used to determine the association between clinical covariates and HRQL, primarily the physical component summary (PCS) and mental component summary (MCS) score. A multivariate regression model was created to identify potential covariates that could help explain the association between the ILD subtype and HRQL.
Results: Patients with IPF (n = 102) were older, more likely to be men, and more likely to have smoked. Pulmonary function was similar between the groups. The patients with CHP (n = 69) had worse HRQL across all eight domains of the SF-36, as well as the PCS and MCS, compared with patients with IPF (P < .01-.09). This pattern remained after controlling for age and pulmonary function (P < .01-.02). Covariates explaining part of the relationship between disease subtype and PCS score included severity of dyspnea (P < .01) and fatigue (P < .01). Covariates explaining part of the relationship between disease subtype and MCS score included severity of dyspnea (P < .01), female sex (P = .02), and fatigue (P = .02).
Conclusions: HRQL is worse in CHP compared with IPF. HRQL differences between ILD subtypes are explained in part by differences in sex, dyspnea, and fatigue.
Figures


Comment in
-
Impaired quality of life in chronic hypersensitivity pneumonitis.Chest. 2015 Jun;147(6):e230. doi: 10.1378/chest.15-0198. Chest. 2015. PMID: 26033140 No abstract available.
Similar articles
-
Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.Respir Med. 2017 Jun;127:1-6. doi: 10.1016/j.rmed.2017.04.002. Epub 2017 Apr 5. Respir Med. 2017. PMID: 28502413 Free PMC article.
-
Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.Respirology. 2017 Nov;22(8):1592-1597. doi: 10.1111/resp.13084. Epub 2017 May 23. Respirology. 2017. PMID: 28544079
-
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.Respir Res. 2020 Dec 7;21(1):322. doi: 10.1186/s12931-020-01579-7. Respir Res. 2020. PMID: 33287805 Free PMC article.
-
A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.Dan Med J. 2015 Apr;62(4):B5069. Dan Med J. 2015. PMID: 25872544 Review.
-
Interstitial Lung Diseases in Developing Countries.Ann Glob Health. 2019 Jan 22;85(1):4. doi: 10.5334/aogh.2414. Ann Glob Health. 2019. PMID: 30741505 Free PMC article. Review.
Cited by
-
Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go.Am J Respir Crit Care Med. 2017 Sep 15;196(6):690-699. doi: 10.1164/rccm.201608-1675PP. Am J Respir Crit Care Med. 2017. PMID: 28002680 Free PMC article. Review. No abstract available.
-
Pain is a common problem in patients with ILD.Respir Res. 2020 Nov 11;21(1):297. doi: 10.1186/s12931-020-01564-0. Respir Res. 2020. PMID: 33176795 Free PMC article.
-
Hypersensitivity pneumonitis.Nat Rev Dis Primers. 2020 Aug 6;6(1):65. doi: 10.1038/s41572-020-0191-z. Nat Rev Dis Primers. 2020. PMID: 32764620 Review.
-
Evaluation of rheumatoid arthritis and connective tissue disease-related interstitial lung disease with pulmonary physiologic test, HRCT, and patient-based measures of dyspnea and functional disability.Clin Rheumatol. 2021 Sep;40(9):3797-3805. doi: 10.1007/s10067-021-05693-9. Epub 2021 Apr 3. Clin Rheumatol. 2021. PMID: 33811590
-
Interventions to improve quality of life and knowledge in Hypersensitivity Pneumonitis, a survey of clinician practices and perspectives.CHEST Pulm. 2024 Dec;2(4):100083. doi: 10.1016/j.chpulm.2024.100083. Epub 2024 Jul 6. CHEST Pulm. 2024. PMID: 39742153
References
-
- De Vries J, Drent M. Quality of life and health status in interstitial lung diseases. Curr Opin Pulm Med. 2006;12(5):354-358 - PubMed
-
- Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest. 1999;116(5):1175-1182 - PubMed
-
- Ware JE., Jr Conceptualization and measurement of health-related quality of life: comments on an evolving field. Arch Phys Med Rehabil. 2003;84(4 suppl 2):S43-S51 - PubMed
-
- Edgell ET, Coons SJ, Carter WB, et al. A review of health-related quality-of-life measures used in end-stage renal disease. Clin Ther. 1996;18(5):887-938 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources